Okada S - Search Results

1

Does homozygosity advance the onset of dentatorubral-pallidoluysian atrophy?

Sato K, Kashihara K, Okada S, Ikeuchi T, Tsuji S, Shomori T, Morimoto K, Hayabara T. Sato K, et al. Among authors: okada s. Neurology. 1995 Oct;45(10):1934-6. doi: 10.1212/wnl.45.10.1934. Neurology. 1995. PMID: 7477999

2

Temporal pattern of AP-1 DNA-binding activity in the rat hippocampus following a kindled seizure.

Kashihara K, Sato K, Akiyama K, Okada S, Ishihara T, Hayabara T, Shomori T. Kashihara K, et al. Among authors: okada s. Neuroscience. 1997 Oct;80(3):753-61. doi: 10.1016/s0306-4522(97)00133-4. Neuroscience. 1997. PMID: 9276491

3

Activator protein-1 binding activities in discrete regions of rat brain after acute and chronic administration of methamphetamine.

Ishihara T, Akiyama K, Kashihara K, Ujike H, Hamamura T, Okada S, Kuroda S. Ishihara T, et al. Among authors: okada s. J Neurochem. 1996 Aug;67(2):708-16. doi: 10.1046/j.1471-4159.1996.67020708.x. J Neurochem. 1996. PMID: 8764599

4

Clinofibrate therapy raises high-density lipoprotein levels and lowers atherogenic index in diabetes mellitus patients.

Okada S, Miyai Y, Ichiki K, Sato K, Masaki Y, Higuchi T, Ogino Y, Ota Z. Okada S, et al. J Int Med Res. 1989 Nov-Dec;17(6):521-5. doi: 10.1177/030006058901700604. J Int Med Res. 1989. PMID: 2628128

5

Influence of prostaglandin E1 on slight proteinuria in non-azotaemic diabetics.

Okada S, Sato K, Higuchi T, Ichiki K, Tanokuchi S, Ishii K, Hamada H, Ota Z. Okada S, et al. J Int Med Res. 1992 Feb;20(1):94-7. doi: 10.1177/030006059202000111. J Int Med Res. 1992. PMID: 1568524

6

Influence of prostaglandin E1 on heavy proteinuria in slightly azotaemic diabetics.

Okada S, Sato K, Higuchi T, Ichiki K, Tanokuchi S, Ishii K, Hamada H, Ota Z. Okada S, et al. J Int Med Res. 1991 Mar-Apr;19(2):171-3. doi: 10.1177/030006059101900212. J Int Med Res. 1991. PMID: 1864454

7

Does protease inhibitor inhibit complement activation caused by the immune complex associated with islet cell surface antibody?

Okada S, Sato K, Ichiki K, Tanokuchi S, Ishii K, Ota Z, Takeda A. Okada S, et al. J Int Med Res. 1991 May-Jun;19(3):234-6. doi: 10.1177/030006059101900309. J Int Med Res. 1991. PMID: 1936512

8

Serum C3 and C4 levels and complement-dependent antibody-mediated cytotoxic activity of islet cell surface antibody in type 1 (insulin-dependent) diabetic children.

Okada S, Sato K, Miyai Y, Masaki Y, Higuchi T, Ogino Y, Ota Z. Okada S, et al. Diabetologia. 1987 Nov;30(11):869-73. doi: 10.1007/BF00274796. Diabetologia. 1987. PMID: 3328722

9

Decreased creatinine clearance which may be observed during prostaglandin E1 therapy: is it reversible with discontinuation of therapy?

Okada S, Miyai Y, Sato K, Higuchi T, Ichiki K, Tanokuchi S, Ishii K, Hamada H, Ota Z. Okada S, et al. J Int Med Res. 1991 Nov-Dec;19(6):493-6. doi: 10.1177/030006059101900610. J Int Med Res. 1991. PMID: 1773910

10

Complement activation pathways associated with islet cell surface antibody (ICSA) derived from child patients with insulin-dependent diabetes mellitus (IDDM).

Okada S, Ichiki K, Sato K, Tanokuchi S, Ishii K, Hamada H, Ota Z. Okada S, et al. Acta Med Okayama. 1991 Jun;45(3):185-6. doi: 10.18926/AMO/32207. Acta Med Okayama. 1991. PMID: 1909828

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

4,541 results

Search Page

Filters